Profile data is unavailable for this security.
About the company
CanadaBis Capital Inc. is a vertically integrated Canadian cannabis company. The Company’s principal business is the production and sale of recreational cannabis and cannabis extracts. The Company operates through three segments: Cultivation and wholesale, Retail and Extract. The Cultivation and wholesale segment is engaged in cultivating and distributing cannabis and cannabis products to and through, provincial liquor and cannabis boards, which are subsequently sold to end consumers. Its Retail segment is involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the Company. Its Extract segment provides cannabinoid extraction services for the Company and also to other licensed producers. The Company’s subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd., Full Spectrum Labs Ltd., 2103157 Alberta Ltd., and Goldstream Cannabis Inc.
- Revenue in CAD (TTM)20.91m
- Net income in CAD3.27m
- Incorporated2016
- Employees--
- LocationCanadaBis Capital Inc255C Clearview DriveRED DEER COUNTY T4E 3B6CanadaCAN
- Phone+1 (587) 356-5625
- Fax+1 (587) 356-5625
- Websitehttps://canadabis.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeo Pharma Inc | 54.29m | -28.43m | 9.37m | 100.00 | -- | -- | -- | 0.1727 | -0.3255 | -0.3255 | 0.6249 | -0.4765 | 1.23 | 3.53 | 12.39 | 434,296.00 | -64.52 | -64.35 | -215.78 | -113.22 | 21.38 | 23.88 | -52.37 | -69.71 | 0.2974 | -1.33 | 3.51 | -- | 94.31 | 65.20 | -8.01 | -- | 76.61 | -- |
| Medicure Inc | 21.76m | -1.16m | 10.44m | 25.00 | -- | 0.509 | 10.30 | 0.4796 | -0.1122 | -0.1122 | 2.02 | 1.96 | 0.7499 | 2.52 | 4.11 | 870,400.00 | -4.00 | -13.42 | -5.46 | -18.28 | 64.75 | 61.87 | -5.33 | -27.38 | 1.59 | -- | 0.0227 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
| CanadaBis Capital Inc | 20.91m | 3.27m | 11.73m | -- | 3.59 | 1.44 | 2.90 | 0.561 | 0.0237 | 0.0237 | 0.1514 | 0.0592 | 0.9778 | 1.90 | 9.81 | -- | 15.27 | -20.55 | 27.30 | -54.86 | 52.50 | -- | 15.62 | -26.61 | 0.5509 | 7.88 | 0.4948 | -- | 90.44 | -- | 630.61 | -- | 238.08 | -- |
| Delivra Health Brands Inc | 12.11m | -711.00k | 12.50m | -- | -- | 3.51 | 20.63 | 1.03 | -0.0026 | -0.0026 | 0.0426 | 0.0114 | 1.23 | 2.50 | 7.19 | -- | -7.25 | -45.81 | -14.01 | -58.34 | 55.93 | 37.95 | -5.87 | -289.55 | 1.50 | 0.0091 | 0.3613 | -- | 20.30 | 68.26 | 97.37 | -- | -56.72 | -- |
| Sirona Biochem Corp | 36.35k | -2.65m | 14.11m | -- | -- | -- | -- | 388.03 | -0.0105 | -0.0105 | 0.0001 | -0.011 | 0.0492 | -- | 7.70 | -- | -358.70 | -173.09 | -- | -383.49 | -- | -- | -7,297.85 | -1,405.28 | -- | -9.04 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
